Mitochondrial permeability transition pore opening as a promising therapeutic target in cardiac diseases

Journal of Pharmacology and Experimental Therapeutics

Volumn 330, Issue 3, 2009, Pages 670-678

  Javadov, Sabzali ^a   Karmazyn, Morris ^b   Escobales, Nelson ^a  

^a UNIVERSITY OF PUERTO RICO SCHOOL OF MEDICINE   (Puerto Rico)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE NUCLEOTIDE TRANSLOCASE; ADENOSINE DIPHOSPHATE; BONGKREKIC ACID; CARIPORIDE; CARRIER PROTEIN; CYCLOPHILIN D; CYCLOSPORIN A; CYCLOSPORIN A [3 N METHYL DEXTRO ALANINE 4 N ETHYLVALINE]; CYCLOSPORIN A [4 N METHYLISOLEUCINE]; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; NORPHENAZONE; PHOSPHATE; PROPOFOL; PYRUVIC ACID; REACTIVE OXYGEN METABOLITE; RO 68 3400; SANGLIFEHRIN A; UBIQUINONE DERIVATIVE; UNCLASSIFIED DRUG; VOLTAGE DEPENDENT ANION CHANNEL;

APOPTOSIS; ARTICLE; CELL DEATH; GENETIC ANALYSIS; HEART DISEASE; HEART FAILURE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HUMAN; MITOCHONDRIAL PERMEABILITY; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEIN TARGETING;

ANIMALS; CARDIOVASCULAR AGENTS; HEART DISEASES; HEART FAILURE; HUMANS; MITOCHONDRIA; MITOCHONDRIAL MEMBRANE TRANSPORT PROTEINS; REPERFUSION INJURY;

EID: 70349105567     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.109.153213     Document Type: Article

References (112)

1. Adachi M, Higuchi H, Miura S, Azuma T, Inokuchi S, Saito H, Kato S, and Ishii H (2004) Bax interacts with the voltage-dependent anion channel and mediates ethanol-induced apoptosis in rat hepatocytes. Am J Physiol Gastrointest Liver Physiol 287:G695-G705. (Pubitemid 39096637)
2. Adams JW, Pagel AL, Means CK, Oksenberg D, Armstrong RC, and Brown JH (2000) Cardiomyocyte apoptosis induced by Gαq signaling is mediated by permeability transition pore formation and activation of the mitochondrial death pathway. Circ Res 87:1180-1187.
3. Adlam VJ, Harrison JC, Porteous CM, James AM, Smith RA, Murphy MP, and Sammut IA (2005) Targeting an antioxidant to mitochondria decreases cardiac ischemia-reperfusion injury. FASEB J 19:1088-1095.
4. Akao M, O'Rourke B, Teshima Y, Seharaseyon J, and Marbán E (2003) Mechanistically distinct steps in the mitochondrial death pathway triggered by oxidative stress in cardiac myocytes. Circ Res 92:186-194. (Pubitemid 36254274)
5. Alcalá S, Klee M, Fernández J, Fleischer A, and Pimentel-Muiños FX (2008) A high-throughput screening for mammalian cell death effectors identifies the mitochondrial phosphate carrier as a regulator of cytochrome c release. Oncogene 27:44-54.
6. Antonsson B, Montessuit S, Lauper S, Eskes R, and Martinou JC (2000) Bax oligomerization is required for channel-forming activity in liposomes and to trigger cytochrome c release from mitochondria. Biochem J 345:271-278. (Pubitemid 30077167)
7. 2+-induced mitochondrial permeability transition. Cardiovasc Res 61:115-122.
8. Argaud L, Gateau-Roesch O, Muntean D, Chalabreysse L, Loufouat J, Robert D, and Ovize M (2005a) Specific inhibition of the mitochondrial permeability transition prevents lethal reperfusion injury. J Mol Cell Cardiol 38:367-374. (Pubitemid 40215206)
9. Argaud L, Gateau-Roesch O, Raisky O, Loufouat J, Robert D, and Ovize M (2005b) Postconditioning inhibits mitochondrial permeability transition. Circulation 111: 194-197. (Pubitemid 40139731)
10. Baines CP, Kaiser RA, Purcell NH, Blair NS, Osinska H, Hambleton MA, Brunskill EW, Sayen MR, Gottlieb RA, Dorn GW, et al. (2005) Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death. Nature 434:658-662. (Pubitemid 40488559)
11. Baines CP, Kaiser RA, Sheiko T, Craigen WJ, and Molkentin JD (2007) Voltage-dependent anion channels are dispensable for mitochondrial-dependent cell death. Nat Cell Biol 9:550-555. (Pubitemid 46696536)
12. Baines CP and Molkentin JD (2009) Adenine nucleotide translocase-1 induces car- diomyocyte death through upregulation of the pro-apoptotic protein Bax. J Mol Cell Cardiol 46:969-977.
13. Baines CP, Song CX, Zheng YT, Wang GW, Zhang J, Wang OL, Guo Y, Bolli R, Cardwell EM, and Ping P (2003) Protein kinase Cepsilon interacts with and inhibits the permeability transition pore in cardiac mitochondria. Circ Res 92:873-880. (Pubitemid 36542528)
14. Basso E, Fante L, Fowlkes J, Petronilli V, Forte MA, and Bernardi P (2005) Properties of the permeability transition pore in mitochondria devoid of cyclophilin D. J Biol Chem 280:18558-18561. (Pubitemid 41379552)
15. Basso E, Petronilli V, Forte MA, and Bernardi P (2008) Phosphate is essential for inhibition of the mitochondrial permeability transition pore by cyclosporin A and by cyclophilin D ablation. J Biol Chem 283:26307-26311.
16. Bera AK, Ghosh S, and Das S (1995) Mitochondrial VDAC can be phosphorylated by cyclic AMP-dependent protein kinase. Biochem Biophys Res Commun 209:213-217.
17. Bernardi P, Vassanelli S, Veronese P, Colonna R, Szabó I, and Zoratti M (1992) Modulation of the mitochondrial permeability transition pore. Effect of protons and divalent cations. J Biol Chem 267:2934-2939.
18. Bopassa JC, Vandroux D, Ovize M, and Ferrera R (2006) Controlled reperfusion after hypothermic heart preservation inhibits mitochondrial permeability transition-pore opening and enhances functional recovery. Am J Physiol Heart Circ Physiol 291:H2265-H2271. (Pubitemid 44776653)
19. Cesura AM, Pinard E, Schubenel R, Goetschy V, Friedlein A, Langen H, Polcic P, Forte MA, Bernardi P, and Kemp JA (2003) The voltage-dependent anion channel is the target for a new class of inhibitors of the mitochondrial permeability transition pore. J Biol Chem 278:49812-49818. (Pubitemid 37548815)
20. Choksi KB, Boylston WH, Rabek JP, Widger WR, and Papaconstantinou J (2004) Oxidatively damaged proteins of heart mitochondrial electron transport complexes. Biochim Biophys Acta 1688:95-101. (Pubitemid 38264403)
21. Ciminelli M, Ascah A, Bourduas K, and Burelle Y (2006) Short term training attenuates opening of the mitochondrial permeability transition pore without affecting myocardial function following ischemia-reperfusion. Mol Cell Biochem 291:39-47. (Pubitemid 44725300)
22. Clarke SJ, Khaliulin I, Das M, Parker JE, Heesom KJ, and Halestrap AP (2008) Inhibition of mitochondrial permeability transition pore opening by ischemic preconditioning is probably mediated by reduction of oxidative stress rather than mitochondrial protein phosphorylation. Circ Res 102:1082-1090. (Pubitemid 351667862)
23. Clarke SJ, McStay GP, and Halestrap AP (2002) Sanglifehrin A acts as a potent inhibitor of the mitochondrial permeability transition and reperfusion injury of the heart by binding to cyclophilin-D at a different site from cyclosporin A. J Biol Chem 277:34793-34799.
24. Connern CP and Halestrap AP (1992) Purification and N-terminal sequencing of peptidyl-prolyl cis-trans-isomerase from rat liver mitochondrial matrix reveals the existence of a distinct mitochondrial cyclophilin. Biochem J 284:381-385.
25. 2+, calcineurin, and NF-AT. Cell 96:611-614.
26. Crompton M (1999) The mitochondrial permeability transition pore and its role in cell death. Biochem J 341:233-249. (Pubitemid 29373645)
27. 2+-dependent pore in heart mitochondria activated by inorganic phosphate and oxidative stress. Biochem J 255:357-360.
28. Crompton M, Virji S, and Ward JM (1998) Cyclophilin-D binds strongly to complexes of the voltage-dependent anion channel and the adenine nucleotide translocase to form the permeability transition pore. Eur J Biochem 258:729-735. (Pubitemid 28557940)
29. Da Cruz S, Parone PA, and Martinou JC (2005) Building the mitochondrial proteome. Expert Rev Proteomics 2:541-551.
30. De Giusti VC, Correa MV, Villa-Abrille MC, Beltrano C, Yeves AM, de Cingolani GE, Cingolani HE, and Aiello EA (2008) The positive inotropic effect of endothelin-1 is mediated by mitochondrial reactive oxygen species. Life Sci 83:264-271.
31. de Jesú s García-Rivas G, Guerrero-Hernández A, Guerrero-Serna G, Rodríguez- Zavala JS, and Zazueta C (2005) Inhibition of the mitochondrial calcium uniporter by the oxo-bridged dinuclear ruthenium amine complex (Ru360) prevents from irreversible injury in postischemic rat heart. FEBS J 272:3477-3488.
32. de Macedo DV, Nepomuceno ME, and Pereira-da-Silva L (1993) Involvement of the ADP/ATP carrier in permeabilization processes of the inner mitochondrial membrane. Eur J Biochem 215:595-600.
33. Delcayre C and Swynghedauw B (2002) Molecular mechanisms of myocardial remodeling. The role of aldosterone. J Mol Cell Cardiol 34:1577-1584. (Pubitemid 36001997)
34. Di Lisa F and Bernardi P (2006) Mitochondria and ischemia-reperfusion injury of the heart: fixing a hole. Cardiovasc Res 70:191-199.
35. Di Lisa F, Menabò R, Canton M, Barile M, and Bernardi P (2001) Opening of the mitochondrial permeability transition pore causes depletion of mitochondrial and cytosolic NAD+ and is a causative event in the death of myocytes in postischemic reperfusion of the heart. J Biol Chem 276:2571-2575. (Pubitemid 37376632)
36. Garciarena CD, Caldiz CI, Correa MV, Schinella GR, Mosca SM, Chiappe de Cingolani GE, Cingolani HE, and Ennis IL (2008) Na+/H+ exchanger-1 inhibitors decrease myocardial superoxide production via direct mitochondrial action. J Appl Physiol 105:1706-1713.
37. Giordano FJ (2005) Oxygen, oxidative stress, hypoxia, and heart failure. J Clin Invest 115:500-508. (Pubitemid 40322219)
38. Gomez L, Thibault H, Gharib A, Dumont JM, Vuagniaux G, Scalfaro P, Derumeaux G, and Ovize M (2007) Inhibition of mitochondrial permeability transition improves functional recovery and reduces mortality following acute myocardial infarction in mice. Am J Physiol Heart Circ Physiol 293:H1654-H1661. (Pubitemid 47367212)
39. Griffiths EJ and Halestrap AP (1991) Further evidence that cyclosporin A protects mitochondria from calcium overload by inhibiting a matrix peptidyl-prolyl cistrans isomerase. Implications for the immunosuppressive and toxic effects of cyclosporin. Biochem J 274:611-614.
40. Griffiths EJ and Halestrap AP (1995) Mitochondrial non-specific pores remain closed during cardiac ischaemia, but open upon reperfusion. Biochem J 307:93-98.
41. Gurevich RM, Regula KM, and Kirshenbaum LA (2001) Serpin protein CrmA suppresses hypoxia-mediated apoptosis of ventricular myocytes. Circulation 103: 1984-1991.
42. Halestrap AP (2009) What is the mitochondrial permeability transition pore? J Mol Cell Cardiol 46:821-831.
43. Halestrap AP and Brennerb C (2003) The adenine nucleotide translocase: a central component of the mitochondrial permeability transition pore and key player in cell death. Curr Med Chem 10:1507-1525.
44. Halestrap AP, Clarke SJ, and Javadov SA (2004) Mitochondrial permeability transition pore opening during myocardial reperfusion - a target for cardioprotection. Cardiovasc Res 61:372-385. (Pubitemid 38210145)
45. Halestrap AP and Davidson AM (1990) Inhibition of Ca2(+)-induced largeamplitude swelling of liver and heart mitochondria by cyclosporin is probably caused by the inhibitor binding to mitochondrial-matrix peptidyl-prolyl cis-trans isomerase and preventing it interacting with the adenine nucleotide translocase. Biochem J 268:153-160.
46. Halestrap AP, Kerr PM, Javadov S, and Woodfield KY (1998) Elucidating the molecular mechanism of the permeability transition pore and its role in reperfusion injury of the heart. Biochim Biophys Acta 1366:79-94. (Pubitemid 28467024)
47. Halestrap AP and Pasdois P (2009) The role of the mitochondrial permeability transition pore in heart disease. Biochim Biophys Acta doi:10.1016/j.bbabio. 2008.12017.
48. Halestrap AP, Woodfield KY, and Connern CP (1997) Oxidative stress, thiol reagents, and membrane potential modulate the mitochondrial permeability transition by affecting nucleotide binding to the adenine nucleotide translocase. J Biol Chem 272:3346-3354. (Pubitemid 27066829)
49. Hansson MJ, Mattiasson G, Månsson R, Karlsson J, Keep MF, Waldmeier P, Ruegg UT, Dumont JM, Besseghir K, and Elmér E (2004) The nonimmunosuppressive cyclosporin analogs NIM811 and UNIL025 display nanomolar potencies on permeability transition in brain-derived mitochondria. J Bioenerg Biomembr 36:407-413. (Pubitemid 39619849)
50. Hausenloy DJ, Duchen MR, and Yellon DM (2003) Inhibiting mitochondrial permeability transition pore opening at reperfusion protects against ischaemia-reperfusion injury. Cardiovasc Res 60:617-625.
51. Hausenloy DJ, Maddock HL, Baxter GF, and Yellon DM (2002) Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning? Cardiovasc Res 55:534-543. (Pubitemid 34874948)
52. 2+ trigger site. Arch Biochem Biophys 195:460-467.
53. Haworth RA and Hunter DR (2000) Control of the mitochondrial permeability transition pore by high-affinity ADP binding at the ADP/ATP translocase in permeabilized mitochondria. J Bioenerg Biomembr 32:91-96.
54. Houser SR, Piacentino V 3rd, and Weisser J (2000) Abnormalities of calcium cycling in the hypertrophied and failing heart. J Mol Cell Cardiol 32:1595-1607.
55. Ide T, Tsutsui H, Kinugawa S, Utsumi H, Kang D, Hattori N, Uchida K, Arimura K, Egashira K, and Takeshita A (1999) Mitochondrial electron transport complex I is a potential source of oxygen free radicals in the failing myocardium. Circ Res 85:357-363. (Pubitemid 29398868)
56. Javadov S, Baetz D, Rajapurohitam V, Zeidan A, Kirshenbaum LA, and Karmazyn M (2006a) Antihypertrophic effect of Na+/H+ exchanger isoform 1 inhibition is mediated by reduced mitogen-activated protein kinase activation secondary to improved mitochondrial integrity and decreased generation of mitochondrial-derived reactive oxygen species. J Pharmacol Exp Ther 317:1036-1043. (Pubitemid 43764106)
57. Javadov S, Choi A, Rajapurohitam V, Zeidan A, Basnakian AG, and Karmazyn M (2008) NHE-1 inhibition-induced cardioprotection against ischaemia/reperfusion is associated with attenuation of the mitochondrial permeability transition. Cardiovasc Res 77:416-424. (Pubitemid 351197641)
58. Javadov S, Huang C, Kirshenbaum L, and Karmazyn M (2005) NHE-1 inhibition improves impaired mitochondrial permeability transition and respiratory function during postinfarction remodelling in the rat. J Mol Cell Cardiol 38:135-143. (Pubitemid 40038660)
59. Javadov S and Karmazyn M (2007) Mitochondrial permeability transition pore opening as an endpoint to initiate cell death and as a putative target for cardioprotection. Cell Physiol Biochem 20:1-22. (Pubitemid 46956808)
60. Javadov S, Purdham DM, Zeidan A, and Karmazyn M (2006b) NHE-1 inhibition improves cardiac mitochondrial function through regulation of mitochondrial biogenesis during postinfarction remodeling. Am J Physiol Heart Circ Physiol 291: H1722-H1730. (Pubitemid 44497677)
61. Javadov S, Rajapurohitam V, Kilić A, Zeidan A, Choi A, and Karmazyn M (2009) Antihypertrophic effect of NHE-1 inhibition involves GSK-3β-dependent attenuation of mitochondrial dysfunction. J Mol Cell Cardiol 46:998-1007.
62. Javadov SA, Clarke S, Das M, Griffiths EJ, Lim KH, and Halestrap AP (2003) Ischaemic preconditioning inhibits opening of mitochondrial permeability transition pores in the reperfused rat heart. J Physiol 549:513-524. (Pubitemid 36701762)
63. Javadov SA, Lim KH, Kerr PM, Suleiman MS, Angelini GD, and Halestrap AP (2000) Protection of hearts from reperfusion injury by propofol is associated with inhibition of the mitochondrial permeability transition. Cardiovasc Res 45:360-369.
64. Johnson N, Khan A, Virji S, Ward JM, and Crompton M (1999) Import and processing of heart mitochondrial cyclophilin D. Eur J Biochem 263:353-359. (Pubitemid 29337025)
65. Karmazyn M, Kilić A, and Javadov S (2008) The role of NHE-1 in myocardial hypertrophy and remodelling. J Mol Cell Cardiol 44:647-653.
66. Karmazyn M, Sostaric JV, and Gan XT (2001) The myocardial Na+/H+ exchanger: a potential therapeutic target for the prevention of myocardial ischaemic and reperfusion injury and attenuation of postinfarction heart failure. Drugs 61:375-389. (Pubitemid 32270046)
67. Kay JE, Moore AL, Doe SE, Benzie CR, Schönbrunner R, Schmid FX, and Halestrap AP (1990) The mechanism of action of FK 506. Transplant Proc 22:96-99.
68. Kerr PM, Suleiman MS, and Halestrap AP (1999) Reversal of permeability transition during recovery of hearts from ischemia and its enhancement by pyruvate. Am J Physiol 276:H496-H502.
69. 2 radicals in intact hearts with ischemia and reperfusion. Am J Physiol Heart Circ Physiol 284:H566-H574.
70. Khaliulin I, Clarke SJ, Lin H, Parker J, Suleiman MS, and Halestrap AP (2007) Temperature preconditioning of isolated rat hearts-a potent cardioprotective mechanism involving a reduction in oxidative stress and inhibition of the mitochondrial permeability transition pore. J Physiol 581:1147-1161. (Pubitemid 46887984)
71. 2+ overloading, trigger pH- and mitochondrial permeability transition-dependent death of adult rat myocytes after ischemia-reperfusion. Am J Physiol Heart Circ Physiol 290:H2024-H2034.
72. Klingenberg M (2008) The ADP and ATP transport in mitochondria and its carrier. Biochim Biophys Acta 1778:1978-2021.
73. Kokoszka JE, Waymire KG, Levy SE, Sligh JE, Cai J, Jones DP, MacGregor GR, and Wallace DC (2004) The ADP/ATP translocator is not essential for the mitochondrial permeability transition pore. Nature 427:461-465. (Pubitemid 38168501)
74. Krauskopf A, Eriksson O, Craigen WJ, Forte MA, and Bernardi P (2006) Properties of the permeability transition in VDAC1(-/-) mitochondria. Biochim Biophys Acta 1757:590-595. (Pubitemid 43993836)
75. Kuwana T, Mackey MR, Perkins G, Ellisman MH, Latterich M, Schneiter R, Green DR, and Newmeyer DD (2002) Bid, Bax, and lipids cooperate to form supramolecular openings in the outer mitochondrial membrane. Cell 111:331-342. (Pubitemid 35341388)
76. Leung AW, Varanyuwatana P, and Halestrap AP (2008) The mitochondrial phosphate carrier interacts with cyclophilin D and may play a key role in the permeability transition. J Biol Chem 283:26312-26323.
77. Li Y, Johnson N, Capano M, Edwards M, and Crompton M (2004) Cyclophilin-D promotes the mitochondrial permeability transition but has opposite effects on apoptosis and necrosis. Biochem J 383:101-109. (Pubitemid 39389455)
78. Lim SY, Davidson SM, Hausenloy DJ, and Yellon DM (2007) Preconditioning and postconditioning: the essential role of the mitochondrial permeability transition pore. Cardiovasc Res 75:530-535. (Pubitemid 47080966)
79. Luvisetto S, Basso E, Petronilli V, Bernardi P, and Forte M (2008) Enhancement of anxiety, facilitation of avoidance behavior, and occurrence of adult-onset obesity in mice lacking mitochondrial cyclophilin D. Neuroscience 155:585-596.
80. Matas J, Young NT, Bourcier-Lucas C, Ascah A, Marcil M, Deschepper CF, and Burelle Y (2009) Increased expression and intramitochondrial translocation of cyclophilin-D associates with increased vulnerability of the permeability transition pore to stress-induced opening during compensated ventricular hypertrophy. J Mol Cell Cardiol 46:420-430.
81. McStay GP, Clarke SJ, and Halestrap AP (2002) Role of critical thiol groups on the matrix surface of the adenine nucleotide translocase in the mechanism of the mitochondrial permeability transition pore. Biochem J 367:541-548.
82. Min L, Fulton DB, and Andreotti AH (2005) A case study of proline isomerization in cell signaling. Front Biosci 10:385-397. (Pubitemid 40543041)
83. Murphy MP (2009) How mitochondria produce reactive oxygen species. Biochem J 417:1-13.
84. Nakagawa T, Shimizu S, Watanabe T, Yamaguchi O, Otsu K, Yamagata H, Inohara H, Kubo T, and Tsujimoto Y (2005) Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death. Nature 434:652-658. (Pubitemid 40488558)
85. 2+- and mitochondrial-dependent cardiomyocyte necrosis as a primary mediator of heart failure. J Clin Invest 117:2431-2444.
86. Nazareth W, Yafei N, and Crompton M (1991) Inhibition of anoxia-induced injury in heart myocytes by cyclosporin A. J Mol Cell Cardiol 23:1351-1354.
87. Novgorodov SA, Gudz TI, Jung DW, and Brierley GP (1991) The nonspecific inner membrane pore of liver mitochondria: modulation of cyclosporin sensitivity by ADP at carboxyatractyloside-sensitive and insensitive sites. Biochem Biophys Res Commun 180:33-38.
88. Oliveira PJ, Seiça R, Coxito PM, Rolo AP, Palmeira CM, Santos MS, and Moreno AJ (2003) Enhanced permeability transition explains the reduced calcium uptake in cardiac mitochondria from streptozotocin-induced diabetic rats. FEBS Lett 554: 511-514. (Pubitemid 37412541)
89. Piot C, Croisille P, Staat P, Thibault H, Rioufol G, Mewton N, Elbelghiti R, Cung TT, Bonnefoy E, Angoulvant D, et al. (2008) Effect of cyclosporine on reperfusion injury in acute myocardial infarction. N Engl J Med 359:473-481.
90. Prendes MG, Torresín E, Gonzá lez M, Fernández MA, Perazzo JC, Savino EA, and Varela A (2008) Protection of ischaemic-reperfused rat heart by dimethylamiloride is associated with inhibition of mitochondrial permeability transition. Clin Exp Pharmacol Physiol 35:201-206.
91. Rajesh KG, Sasaguri S, Suzuki R, and Maeda H (2003) Antioxidant MCI-186 inhibits mitochondrial permeability transition pore and upregulates Bcl-2 expression. Am J Physiol Heart Circ Physiol 285:H2171-H2178. (Pubitemid 37305962)
92. Regula KM, Ens K, and Kirshenbaum LA (2002) Inducible expression of BNIP3 provokes mitochondrial defects and hypoxia-mediated cell death of ventricular myocytes. Circ Res 91:226-231. (Pubitemid 34875677)
93. Schinzel AC, Takeuchi O, Huang Z, Fisher JK, Zhou Z, Rubens J, Hetz C, Danial NN, Moskowitz MA, and Korsmeyer SJ (2005) Cyclophilin D is a component of mitochondrial permeability transition and mediates neuronal cell death after focal cerebral ischemia. Proc Natl Acad Sci U S A 102:12005-12010. (Pubitemid 41291119)
94. Shanmuganathan S, Hausenloy DJ, Duchen MR, and Yellon DM (2005) Mitochondrial permeability transition pore as a target for cardioprotection in the human heart. Am J Physiol Heart Circ Physiol 289:H237-H242. (Pubitemid 40934105)
95. Sharov VG, Todor A, Khanal S, Imai M, and Sabbah HN (2007) Cyclosporine A attenuates mitochondrial permeability transition and improves mitochondrial respiratory function in cardiomyocytes isolated from dogs with heart failure. J Mol Cell Cardiol 42:150-158. (Pubitemid 44958623)
96. Sharov VG, Todor AV, Imai M, and Sabbah HN (2005) Inhibition of mitochondrial permeability transition pores by cyclosporine a improves cytochrome c oxidase function and increases rate of ATP synthesis in failing cardiomyocytes. Heart Fail Rev 10:305-310.
97. Sharov VG, Todor AV, Silverman N, Goldstein S, and Sabbah HN (2000) Abnormal mitochondrial respiration in failed human myocardium. J Mol Cell Cardiol 32: 2361-2367. (Pubitemid 32039785)
98. Shimizu S, Matsuoka Y, Shinohara Y, Yoneda Y, and Tsujimoto Y (2001) Essential role of voltage-dependent anion channel in various forms of apoptosis in mammalian cells. J Cell Biol 152:237-250. (Pubitemid 34285595)
99. Shimizu S, Narita M, and Tsujimoto Y (1999) Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC. Nature 399:483-487. (Pubitemid 29258855)
100. Sutton MG and Sharpe N (2000) Left ventricular remodeling after myocardial infarction: pathophysiology and therapy. Circulation 101:2981-2988. (Pubitemid 30415891)
101. Szabó I, De Pinto V, and Zoratti M (1993) The mitochondrial permeability transition pore may comprise VDAC molecules. II. The electrophysiological properties of VDAC are compatible with those of the mitochondrial megachannel. FEBS Lett 330:206-210. (Pubitemid 23265132)
102. Takeda T, Akao M, Matsumoto-Ida M, Kato M, Takenaka H, Kihara Y, Kume T, Akaike A, and Kita T (2006) Serofendic acid, a novel substance extracted from fetal calf serum, protects against oxidative stress in neonatal rat cardiac myocytes. J Am Coll Cardiol 47:1882-1890.
103. 2+ and oxidant stress. Eur J Biochem 238:166-172.
104. Terrones O, Antonsson B, Yamaguchi H, Wang HG, Liu J, Lee RM, Herrmann A, and Basañez G (2004) Lipidic pore formation by the concerted action of proapoptotic BAX and tBID. J Biol Chem 279:30081-30091. (Pubitemid 38937930)
105. Teshima Y, Akao M, Jones SP, and Marbán E (2003) Cariporide (HOE642), a selective Na+-H+ exchange inhibitor, inhibits the mitochondrial death pathway. Circulation 108:2275-2281. (Pubitemid 37363047)
106. Vassilopoulos A and Papazafiri P (2005) Attenuation of oxidative stress in HL-1 cardiomyocytes improves mitochondrial function and stabilizes Hif-1alpha. Free Radic Res 39:1273-1284. (Pubitemid 43023792)
107. Waldmeier PC, Feldtrauer JJ, Qian T, and Lemasters JJ (2002) Inhibition of the mitochondrial permeability transition by the nonimmunosuppressive cyclosporin derivative NIM811. Mol Pharmacol 62:22-29. (Pubitemid 34680512)
108. Wang G, Liem DA, Vondriska TM, Honda HM, Korge P, Pantaleon DM, Qiao X, Wang Y, Weiss JN, and Ping P (2005) Nitric oxide donors protect murine myocardium against infarction via modulation of mitochondrial permeability transition. Am J Physiol Heart Circ Physiol 288:H1290-H1295. (Pubitemid 40270036)
109. Woodfield K, Rück A, Brdiczka D, and Halestrap AP (1998) Direct demonstration of a specific interaction between cyclophilin-D and the adenine nucleotide translocase confirms their role in the mitochondrial permeability transition. Biochem J 336:287-290. (Pubitemid 28564382)
110. Xu M, Wang Y, Hirai K, Ayub A, and Ashraf M (2001) Calcium preconditioning inhibits mitochondrial permeability transition and apoptosis. Am J Physiol Heart Circ Physiol 280:H899-H908. (Pubitemid 32466936)
111. Zhou S, Heller LJ, and Wallace KB (2001) Interference with calcium-dependent mitochondrial bioenergetics in cardiac myocytes isolated from doxorubicin-treated rats. Toxicol Appl Pharmacol 175:60-67. (Pubitemid 32783536)
112. Zoratti M, Szabò I, and De Marchi U (2005) Mitochondrial permeability transitions: how many doors to the house? Biochim Biophys Acta 1706:40-52.